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Abstract
Background: Screening programs may help to address the burden of chronic kidney disease (CKD) in Australia.
Public awareness is an important determinant of the uptake of screening programs. However, data on the public
knowledge of CKD in Australia is lacking. The aim of this study was to develop a validated questionnaire and assess
the Australian public knowledge of CKD.
Methods: A CKD knowledge questionnaire was developed after reviewing the literature and discussions with
nephrology experts. Content validity was performed by nephrologists (n = 3), renal nurses (n = 3) and research
personnel (n = 4). The questionnaire was piloted in 121 public participants. Next, discriminant validation was
performed by recruiting two additional groups of participants: final year undergraduate pharmacy students (n = 28)
and nephrologists (n = 27). Reliability of the questionnaire was assessed by calculating Cronbach’s alpha. Next, a
cross-sectional survey of the Australian public (n = 943) was conducted by using the validated questionnaire. It was
administered using an online Omnibus survey. Quota sampling was used for participant selection and to ensure
that the final sample would match the key characteristics of the Australian population. Finally, a standard multiple
regression analysis was performed to identify predictors of the public knowledge.
Results: The median CKD knowledge scores of the public, students and nephrologists were 12, 19 and 23
(maximum score of 24), respectively, with statistically significant differences in the scores across the three
groups (p < 0.001; Kruskal-Wallis test). The Cronbach’s alpha was 0.88 (95% CI: 0.86–0.91), indicating that the
questionnaire had good internal consistency. In the cross-sectional survey of the Australian public, the
participants’ mean (SD) age was 47.6 (±16.6) years and 51.2% were female. The mean (SD) knowledge score
was 10.3 (± 5.0). The multivariate analysis showed that participants with a higher level of education; with a
family history of kidney failure; with a personal history of diabetes; and currently or previously living in a
relationship had significantly higher knowledge scores.
Conclusion: The Australian public knowledge of CKD was relatively poor. Improving public knowledge may
assist in increasing early detection and subsequent management of CKD in Australia.
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Background
Chronic kidney disease (CKD) refers to decreased kid-
ney function, as shown by a glomerular filtration rate
(GFR) of less than 60 mL/min per 1·73 m2, or
markers of kidney damage, or both, of at least
3 months duration [1, 2]. CKD is a major risk factor
for end-stage kidney disease, cardiovascular disease
and premature death [3]. The global burden of CKD
has increased significantly, causing > 500,000 deaths
since 1990 [4, 5]. Between 2005 and 2013, the global
age-standardised mortality rate for CKD has increased
by approximately 37% [4]. Despite this, CKD has re-
ceived relatively limited global attention and needs ef-
fective public health interventions for prevention and
management [4].
Early detection and treatment of CKD in its initial
stages may help in the prevention or delaying of dis-
ease progression [6]. Many clinical practice guidelines
for CKD, such as Kidney Health Australia (KHA) -
Caring for Australasians with Renal Impairment
(CARI), recommend screening of people with risk fac-
tors for CKD [6–8] and several screening programs
have been conducted worldwide to identify people
with early stages of CKD within the community [9].
A screening program conducted within the Australian
community setting concluded that implementation of
targeted ‘opportunistic’ screening for CKD within pri-
mary care might be a sustainable approach [10], while
public screening for CKD is not routinely practiced at
present in Australia [11].
More generally, health promotion and early detection
are important strategies adapted by the Australian gov-
ernment within the national health policy to address in-
creasing rates of chronic diseases [12]. However, there
appears to be a lack of understanding amongst the Aus-
tralian community about the preventability of major
health conditions [13, 14]. An Australian survey, which
included items to determine the public’s ability to adopt
disease preventive measures and engage in early detec-
tion by understanding health alerts in the media and
public displays for inoculations and screening, found less
than adequate levels of health literacy in approximately
60% of participants [15]. Limited public knowledge of
the particular disease itself is another important barrier
to the successful implementation of prevention pro-
grams [13, 16, 17]. For instance, a cross-sectional survey
of Australian adults showed that even amongst sub-
groups of cohorts with the greatest risk of CKD, the
knowledge of CKD risk factors and the recall of kidney
function testing were both limited [17].
Public awareness of CKD is an important determinant
of the uptake of screening programs [18, 19], which may
help to address the CKD burden. Determining the public
knowledge of CKD can also provide guidance to medical
health professionals, researchers and kidney health orga-
nisations when establishing the need for education cam-
paigns. The few studies conducted to assess the public
knowledge of CKD, used questionnaires that were not
validated [17, 20–22], with no such study performed in
the general Australian population. Therefore, the pri-
mary aim of this study was to determine knowledge of
CKD in the Australian public using a newly developed
and validated questionnaire. The secondary aim was to
determine potential predictors of CKD knowledge in the
Australian public.
Methods
This study involved two phases: Phase 1) Development
and validation (content and discriminant validity) of the
CKD knowledge questionnaire, and Phase 2) A cross-
sectional survey to evaluate the Australian public know-
ledge of CKD.
Phase 1) development and validation
The initial draft of the CKD knowledge questionnaire
was generated through literature review of existing pub-
lic [20–22] and related questionnaires [17, 23–27], fol-
lowing discussions with nephrology and research
experts. The questionnaire was divided into 5 sections
and included a total of 35 evidence-based questions on
the physiology of the kidneys, ‘Kidney Health Check’
[28], risk factors for CKD [29] and signs and symptoms
of advanced CKD or kidney failure. Seven control items
were added to the questionnaire for methodological val-
idity. The questionnaire was reviewed for content and
face validity by nephrologists (n = 3), renal nurses (n = 3)
and research personnel (n = 4). For each section, re-
viewers were asked to evaluate individual items and
highlight those that were deemed inappropriate in terms
of phrasing and applicability. Consequently, items that
would require a clinical level of expertise were deleted,
and several items were rephrased so that a layperson
could better understand them. The final draft of the
questionnaire is provided as an Additional file 1. The
questionnaire consisted a total of 24 questions with the
multiple-choice options ‘True’, ‘False’ and ‘I don’t know’.
Correct responses were given a score of 1 and incorrect
responses were given a score of 0. The option ‘I don’t
know’ was considered as lack of knowledge and given a
score of 0.
Next, the questionnaire was piloted and involved re-
cruitment of eligible people visiting the central shopping
district and a suburban shopping centre in Hobart, Tas-
mania. Eligible people were adults (≥18 years) who were
not registered healthcare professionals, such as a doctor,
nurse, pharmacist or dietitian, and did not have a per-
sonal history of kidney failure. A researcher visually de-
termined the eligibility of a potential participant and
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approached them for participation. Those willing to par-
ticipate (after confirmation of eligibility) were required
to complete the questionnaire on the spot. The first five
participants additionally assessed the questionnaire for
clarity, formatting and phrasing. Sample size for this
pilot phase was calculated as per the recommendations
made by Viechtbaur et al. [30]. To be 99% certain that
the pilot study would detect any unforeseen problems
e.g. misinterpretations of the questionnaire items with a
problem probability of 0.05, at least 90 participants was
needed.
To determine the discriminant validity of the ques-
tionnaire, two additional groups of participants were re-
cruited: final (fourth) year undergraduate pharmacy
students and nephrologists. Pharmacy students from the
University of Tasmania were invited to answer the self-
administered questionnaire during their regular univer-
sity tutorial sessions. Nephrologists completed an online
questionnaire following recruitment through an adver-
tisement in the Australian and New Zealand Society of
Nephrology’s weekly newsletter. No previous data (from
a pilot study) was available to perform a statistical power
analysis for sample size estimation. Therefore, choosing
a large effect size of 0.40, with an alpha = 0.05 and
power = 0.80, the projected sample size needed was ap-
proximately N = 66 (22 per group) for between-group
comparisons [31]. It was hypothesised that the average
knowledge score would be highest for nephrologists,
followed by students and lastly the public.
Reliability of the questionnaire was measured by
calculating the Cronbach’s alpha. Next, normality of
distributions of the continuous variable was deter-
mined using the Shapiro-Wilk test. The Kruskal-
Wallis test was used to determine if there were any
statistically significant differences between the know-
ledge scores of the three groups (i.e. public, students
and nephrologists). Post-hoc tests were performed
using Mann-Whitney U tests to determine which
groups were significantly different (p < 0.005) from
one another.
Phase 2) cross-sectional survey
The above-validated questionnaire was used to evaluate
the public knowledge of CKD. Based on the Phase 1
data, it was estimated that at least 50% of the sample
would have a total score of at least 50% of the maximum
achievable score on the questionnaire. Using a 5% preci-
sion and 99% confidence level, to be 99% sure that the
true percentage of the public that would achieve at least
50% score on the questionnaire was between 45% and
55%, 665 eligible participants were needed. The ques-
tionnaire was administered using I-view’s (an Australian
market and social research data collection agency;
http://www.iview.com.au/) online Omnibus service [32].
The Omnibus is conducted over a period of 1 week once
fortnightly, and provides a national sample of 1000
adults (≥18 years). I-view’s online panel ‘MyView’ was
used as the sampling frame; it consists of approximately
130,000 Australian adults (≥18 years) and overseas visi-
tors staying or intending to stay in Australia for
12 months or more. Quotas were set according to age,
gender and geographical locations (divided according to
state, and by metropolitan and rural areas) to ensure
that the final sample would match the characteristics of
the Australian population, as per the Australian Bureau
of Statistics (ABS) 2011-census data.
The online Omnibus was conducted between 2nd and
6th November 2016. Respondents who completed the
survey in under half of the median survey length were
identified as skimmers and excluded. Post-stratification
was used to make adjustment to the weights so that the
resultant weighted estimates from the sample conform
to the Australian population values for age, gender and
location. The sample (cross-sectional survey data) joint
distribution and population (ABS census 2011 data) joint
distribution of all three variables (age range, gender and
location) was determined. Post-stratification was per-
formed using the rim weighting method. Rim weighting
allows benchmarking sample distributions to that of the
population distributions. It is an iterative proportional
fitting procedure, where all three variables were simul-
taneously weighted until a convergence was reached.
After the weighted data was obtained from I-view, par-
ticipants were excluded if they identified themselves as a
healthcare professional (such as a doctor, nurse, pharma-
cist or dietitian) or had a personal history of kidney dis-
ease. Given the large sample size, the central limit
theorem holds true, and it was reasonably assumed that
the distribution of the total score would be approxi-
mately normally distributed [33]. Next, bivariate analyses
was performed using one-way ANOVA and independent
t-tests, as appropriate, to compare the effect of partici-
pants’ sociodemographic characteristics on the CKD
knowledge score. A multivariable linear regression
model was then constructed to predict the knowledge
score based on potential predictor variables (p < 0.10,
using bivariate analysis), and a standard multiple regres-
sion analysis was performed. We confirmed the assump-
tions of normality, linearity and multicollinearity.
The Statistical Package for the Social Sciences (IBM
SPSS Statistics for Windows, Version 23.0 Armonk, NY:
IBM Corp. SPSS) and G*Power version 3.1 were used to
perform all the statistical analyses.
Results
Phase 1) development and validation
Complete responses were received from 27 students, 28
nephrologists and 121 participants from the public, and
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these were included in the final analysis. These corre-
sponded to over 85% of the students and members of
the public approached, while the nephrologists volun-
tarily accessed the online questionnaire. An additional
file shows the percentage of correct responses to indi-
vidual items on the questionnaire by all three groups
[see Additional file 2]. The Cronbach’s alpha was 0.88
(95% CI: 0.86–0.91), indicating that the questionnaire
had good internal consistency.
The p-value for the Shapiro-Wilk test was < 0.05 for
each group, indicating that the data was not normally
distributed. Therefore, non-parametric statistical tests
were used to perform subsequent analyses. The Kruskal-
Wallis test revealed a statistically significant difference
in the total score of participants across the three groups
(χ2 (2, N = 176) = 109.7, p < 0.001). The median total
scores of the nephrologists, students and public were 23,
19 and 12, respectively. Post-hoc comparisons performed
between pairs of groups found statistically significant
differences between all three groups (p < 0.001).
Phase 2) cross-sectional survey
A total of N = 24,662 people were invited to participate
in the online Omnibus survey. The survey was closed
after 1 week, during which time 2173 people accessed
the survey and 1034 provided complete responses (re-
sponse rate of 4.2%). A total of 73 participants were
identified as a registered healthcare professional or had a
personal history of kidney disease, and 18 had unclear
sociodemographic characteristics; these were excluded.
Thus, a sample of 943 participants was included in the
final analysis, and Table 1 shows participant characteris-
tics and their comparison with the Australian public.
Since this sample was matched to only Australian public
values for age, gender and location, there are differences
in the proportions under the categories education and
country of birth. More specifically, this sample had a
higher proportion of Australian-born participants and
individuals who were higher degree/postgraduate dip-
loma/bachelor degree holders and diploma/vocational
holders.
The mean (SD) knowledge score of the Australian
public was 10.34 (± 5.0), with values ranging from 0 to
22. As shown in Fig. 1 Distribution of the chronic kidney
disease knowledge scores of the Australian public, 50%
of the participants had knowledge scores less than 11.
Table 2 shows the percentage of participants with cor-
rect responses to individual items on the questionnaire.
Most participants knew that kidneys make urine (62.1%)
and clean blood (69.8%); however, few identified that
kidneys help to maintain blood pressure (BP) (26.4%)
and keep the bones healthy (14.3%). Many participants
identified diabetes (60.6%) as a risk factor, but hyperten-
sion (38.3%) was less frequently recognised. Most
participants knew that urine (76.2%) and blood (68.2%)
tests help to determine the kidney health; however, only
20.3% people knew that BP monitoring also helps in
evaluating kidney health. Only 23.4% knew that herbal
supplements are not effective in treating CKD and just
over 50% knew that medication could help in delaying
the progression of CKD.
Results of the bivariate analysis performed using one-
way ANOVA tests between individual participant charac-
teristics and total score is shown in an Additional file 3.
The analysis of variance showed significant associations
between the CKD knowledge score and sociodemographic
variables, such as age, education, occupation, annual in-
come and marital status, and a personal history of hyper-
tension, diabetes, heart disease and stroke (p < 0.01). An
additional file shows the results of the bivariate ana-
lysis performed using independent t-tests between in-
dividual participant characteristic and total score [see
Additional file 4]. There was a significant difference
(p < 0.01) in the knowledge scores of participants with
and without a family history of kidney failure.
A multiple linear regression was performed to predict
the CKD knowledge score based on age, education, oc-
cupation, marital status, family history of kidney failure,
and a personal history of hypertension, diabetes, heart
disease and stroke. The bivariate analysis showed that
participants who refused to reveal their annual income
had statistically significantly lower knowledge scores
than the other category participants. This participant
characteristic was excluded because practically it would
not have made a unique contribution to a model that
could be used to predict knowledge scores. Table 3
shows the results of the standard multiple regression
analysis between CKD knowledge score and participant
characteristics. A significant regression equation was
found (F (21,921) = 4.58, p < 0.001), with an R2 of 0.095.
The multivariate analysis found higher knowledge scores
associated with a higher level of education, such as pos-
sessing a postgraduate diploma or bachelor degree and
diploma/vocational certificate. A family history of kidney
failure was also independently associated with higher
knowledge scores, as was a personal history of diabetes.
Finally, participants currently or previously within a rela-
tionship (married, de-facto, living with a partner or di-
vorced/separated/widowed) had significantly higher
knowledge scores than those who were single/never
married.
Discussion
Overall, the results of this study show poor understand-
ing of CKD amongst the Australian public. Participants
in this study had limited knowledge of the physiological
role of the kidneys, especially relating to the regulation
of BP, and bone development and metabolism.
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Table 1 Participant characteristics and their comparison with the Australian public
Characteristics Participants Australian public
N % N %
Total 943 100 16,517,613 100
Age (Mean ± S.D., range) 47.6 ± 16.6, 18–84
Age range (years)a
18–29 181 19.2 3,533,626 21.4
30–49 347 36.8 6,020,939 36.4
50 + 415 44.0 6,963,048 42.2
Gendera
Female 483 51.2 8,446,803 51.1
Male 460 48.8 8,070,810 48.8
Country of birth
Australia 727 77.1 10,674,865 64.6
Not Australia 216 22.9 5,842,748 35.4
Education`
Higher degree or postgraduate diploma/Bachelor degree 299 31.7 3,268,574 19.8
Diploma/Vocational 345 36.6 1,392,191 8.4
Completed highest level of school 178 18.9 2,639,997 16.0






Other occupations 53 5.6
Do not work 420 44.5
Work outside home
Yes, full-time 331 35.1
Yes, part-time 192 20.4
No (Not employed, student, work at home, homemaker, retired, etc.) 420 44.5
Gross annual income
Under $50,000 348 36.9
$50,000 to just under $100,000 281 29.8
$100,000 and over 208 22.1
Refused 103 11.2
Marital status
Married/Common law, De-facto or Living with a partner 568 60.2
Single/Never married 227 24.1
Divorced/Separated/Widowed 148 15.7
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Table 1 Participant characteristics and their comparison with the Australian public (Continued)
Characteristics Participants Australian public
N % N %
Five or more 73 7.7




Within a capital city 535 56.7
Within a major regional city 234 24.8
Within a rural town or its surrounds 144 15.3
More than 5 km from the nearest town 30 3.2
Statea
New South Wales 296 31.4 5,316,815 32.2
Victoria 257 27.3 4,149,390 25.1
Queensland 181 19.2 3,278,855 19.8
Western Australia 85 9.0 1,709,692 10.4
South Australia 84 8.9 1,247,852 7.6
Tasmania 24 2.5 381,299 2.3
Australian Capital Territory 13 1.4 277,559 1.7
Northern Territory 3 0.3 153,716 0.9
Other territories 0 0 2433 0.0
Aboriginal or Torres Strait Islander descent
Yes 15 1.6 10,329 0.1
No 928 98.4 16,507,284 99.9
Family member working as a registered healthcare professional e.g. doctor, nurse, dietician or pharmacist
Yes 55 5.8
No 888 94.2
Family history of kidney failure
Yes 47 5.0
No 896 95.0
Medical condition(s)/illness(es) that require regular medications
High blood pressure known as hypertension
Yes 220 23.3
No 704 74.7
I don’t know 19 2.0
Raised blood sugar known as diabetes
Yes 81 8.6
No 840 89.1
I don’t know 22 2.3
Heart problems such as heart failure or heart attack
Yes 42 4.5
No 877 93.0
I don’t know 24 2.5
Personal history of stroke
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Participant knowledge about CKD risk factors was also
limited. Less than half of the participants correctly iden-
tified hypertension as a risk factor. This percentage was
higher, however, than the 2.8% reported in a study of
852 Australians by White et al. [17] In a public survey of
748 participants conducted in Iran [21], only 14.4% se-
lected ‘unmanaged hypertension’ as ‘very likely to result
in CKD’; whereas, a study of 516 community-dwelling
Hong Kong adults reported that 43.8% participants knew
that hypertension can cause kidney disease [20]. Add-
itionally, a cross-sectional study of 454 participants con-
ducted in South-West Nigeria found that 54.7% believed
that hypertension was a CKD risk factor [22]. Con-
versely, the percentage of participants (60.6%) who cor-
rectly identified diabetes as a risk factor in this study
was high as compared to the 8.6%, 12.7%, 44.0% and
49.0% reported by White et al. [17] Roomizadeh et al.
[21], Chow et al. [20] and Oluyombo et al. [22],
respectively.
Only half of the participants knew that medications
can help to slow the worsening of CKD. This suggests
that the Australian public understanding of the treat-
ment of kidney failure is relatively poor. In addition, only
23.4% of participants knew that herbal supplements are
ineffective in treating CKD. Some herbal supplements
have been associated with the development of CKD [34]
and related to acute kidney injury [35]. Also, concomi-
tant use of herbs and conventional drugs can cause drug
toxicity and therapeutic failure via alteration in renal
function [36]. With the increasing availability and use of
herbal medicines in high-income countries [37], efforts
should be made to educate people on their potentially
harmful repercussions, and their use should be strongly
discouraged in people with kidney disease.
KHA recommends that people with diabetes or hyper-
tension should undergo a ‘Kidney Health Check’ every
year [28]. A ‘Kidney Health Check’ includes three assess-
ments: a blood test to determine the estimated GFR (in-
dicates level of kidney function); a urine test to check
for albuminuria (marker of kidney damage); and an as-
sessment of BP because kidney disease can be an out-
come of high BP or cause renal hypertension. More than
65% of participants in this study knew that blood and
urine tests can be used to determine kidney health; how-
ever, few correctly identified a BP assessment. Both
hypertension and CKD are silent diseases, which warrant
Table 1 Participant characteristics and their comparison with the Australian public (Continued)
Characteristics Participants Australian public
N % N %
Yes 18 1.9
No 900 95.4
I don’t know 25 2.7
Blanks indicate that the data for the Australian public was not available
aSample was post-weighted to match only three Australian public characteristics (age, gender and state)
`Variables do not add up to total due to education information inadequately described or not stated by the Australian public
Fig. 1 Distribution of the chronic kidney disease knowledge scores of the Australian public
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regular monitoring for prevention and management.
There is a need to create improved awareness about BP,
its regular monitoring and its association with CKD
amongst the Australian public.
The multivariate analysis showed that CKD know-
ledge score increased with a higher level of education;
this is consistent with the findings of other studies
[20, 22]. Additionally, our regression model showed
that participants who were single or never married
had lower CKD knowledge scores. This may be
because people who have lived or are living with
others are more actively involved in acquiring health-
related information and implementing healthy life-
styles [38–41]. Another important predictor variable
was a family history of kidney failure. This was an
expected outcome because knowing a person with
kidney failure would be anticipated to indirectly raise
awareness on the same.
White et al. [17] and Chow et al. [20] found, similar
to this study, that participants with a personal history
of diabetes had better knowledge. Although this pre-
dictor variable reached statistical significance in the
final model, the mean total score of patients with dia-
betes was low (11.8 out of a possible score of 24).
This suggests that even though patients with diabetes
had better knowledge when compared with the
public, their overall CKD knowledge was still poor.
Similarly, even though participants with other existing
co-morbidities had comparatively higher mean scores,
the values were still around half of the maximum
achievable on the questionnaire. This demonstrates
that even amongst the cohorts at highest risk of
Table 2 Percentage of correct response to individual items on the questionnaire by the Australian general population
Item No Question Correct response (%) N = 943
1* A person can lead a normal life with one healthy kidney. 85.6
2 Herbal supplements can be effective in treating chronic kidney disease. 23.4
3* Certain medications can help to slow-down the worsening of chronic kidney disease. 51.2
What functions do the kidneys perform in the body?
4* The kidneys make urine. 62.1
5* The kidneys clean blood. 69.8
6 The kidneys help to keep blood sugar level normal. 22.6
7* The kidneys help to maintain blood pressure. 26.4
8 The kidneys help to breakdown protein in the body. 14.3
9* The kidneys help to keep the bones healthy. 14.3
Which of the following are commonly used to determine health of the kidneys?
10* A blood test. 68.2
11* A urine test. 76.2
12 A faecal test. 45.9
13* Blood pressure monitoring. 20.3
What are the risk factors for chronic kidney disease?
14* Diabetes. 60.6
15 Being female. 42.4
16* High blood pressure. 38.3
17* Heart problems such as heart failure or heart attack. 26.3
18 Excess stress. 16.4
19* Obesity. 58.6
What are the signs and symptoms that a person might have if they have advanced chronic kidney disease or kidney failure?
20* Water retention. (excess water in the body) 61.1
21 Fever. 15.2
22* Nausea/vomiting. 37.6
23* Loss of appetite. 38.4
24* Increased fatigue (tiredness). 58.7
a True items
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developing CKD, awareness is relatively low. The KHA-
CARI guidelines recommend that physicians should pro-
vide early CKD education to patients with CKD risk fac-
tors as this may prevent CKD development and
progression [6]. A recent Australian study conducted to
determine the kidney disease health-literacy among new
patients referred to specialist nephrology care reported
that 35.8% patients had received no education and 46.2%
Table 3 Standard multiple regression analysis between CKD knowledge score and participant characteristics
Characteristics β coefficient (95% CI) p value
Age range (years)
18 – 29a
30–49 −0.06 (−1.56 to 0.25) 0.16
50 + 0.04 (−0.57 to 1.43) 0.40
Education
Did not complete highest level of schoola
Completed highest level of school 0.01 (−0.99 to 1.28) 0.80
Diploma/Vocational 0.11 (0.10 to 2.14) 0.03
Higher degree or post graduate diploma/Bachelor degree 0.16 (0.58 to 2.79) 0.003
Occupation
Do not worka
Unskilled/Labourer −0.04 (−2.35 to 0.43) 0.18
Technical/Skilled −0.01 (−1.27 to 1.10) 0.89
Sales/Clerical −0.02 (− 1.23 to 0.67) 0.57
Professional/Managerial 0.06 (−0.32 to 1.64) 0.11
Other occupations 0.05 (−0.39 to 2.43) 0.16
Marital status
Single/Never marrieda
Married/Common law, De-facto or Living with a partner 0.10 (0.21 to 1.80) 0.01
Divorced/Separated/Widowed 0.10 (0.28 to 2.48) 0.01
Family history of kidney failure
Yes vs No 0.08 (0.39 to 3.24) 0.01
Medical condition(s)/illness(es) that require regular medications
High blood pressure known as hypertension
Yesa
No −0.02 (−1.09 to 0.55) 0.52
I don’t know −0.09 (−6.84 to 0.29) 0.07
Raised blood sugar known as diabetes
Yesa
No −0.09 (−2.54 to − 0.22) 0.02
I don’t know −0.07 (−5.37 to 0.79) 0.15
Heart problems such as heart failure or heart attack
Yesa
No 0.01 (−1.29 to 1.86) 0.73
I don’t know 0.03 (−2.31 to 4.22) 0.57
Personal history of stroke
Yesa
No −0.09 (−4.32 to 0.27) 0.08
I don’t know −0.16 (−8.43 to −1.15) 0.01
aReference; R2 for the model = 0.095
Bold numbers indicate p-values which were found to be statistically significant in the multivaraiate analysis
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had little, but inadequate, information on their kidney
problem [25]. When asked what causes CKD, almost 40%
patients answered ‘unsure’ and approximately 30% an-
swered ‘alcohol’.
Some inconsistencies were found when comparing
the questionnaire results of this study with those of
others. These, in part, may be because of the explora-
tory nature of the questions and non-validated ques-
tionnaires used in other studies. Creating a
questionnaire that can produce valid and reliable data
is a complex process, and guidelines are available for
developing and validating questionnaires before their
use in cross-sectional studies [42–44]. Despite this,
studies have often used non-validated questionnaires
[42]. Prior to the future use of this questionnaire, sev-
eral improvements that could be made include: 1) Re-
phrasing section 2 as “What major functions do the
kidney perform in our body?” (noting that there is
some involvement in controlling blood glucose levels)
and 2) Addition of an item under Section 2 “Kidneys
help in the production of red blood cells” (True
Item).
It is acknowledged that the sample may not have
been truly representative of the general public. It was
weighted to match the Australian population for only
age, gender and location, and had a relatively high
proportion of participants who were higher degree/
postgraduate diploma/bachelor and diploma/vocational
degree holders. Also, more than 20% of the partici-
pants had a gross annual income of $100,000 and
over. Despite this, the mean total score of participants
was less than 50% of the maximum score achievable
on the questionnaire. This suggests that everyone
should be targeted for CKD education, irrespective of
their sociodemographic backgrounds. While the re-
gression model was statistically significant, the R
square value was low. Hence, future studies should
explore additional predictors, which can further assist
in understanding the low CKD knowledge of the
public.
Conclusions
A valid and reliable questionnaire to measure the
CKD knowledge of the general population was devel-
oped and tested in this study. Australian public
knowledge of the physiological role of the kidneys,
and CKD and its risk factors was poor, irrespective of
sociodemographic and clinical characteristics. Health-
care professionals within primary care settings should
evaluate the CKD knowledge of patients with CKD
risk factors and, if warranted, provide tailored educa-
tion. As for the public, there is a need to increase
their understanding of kidneys and knowledge of
CKD through nationwide awareness programs. These
efforts may improve the early detection and manage-
ment of CKD.
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